EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

THE ROLE OF INFILTRATION BY LANGERHANS CELLS IN THE ASSESSMENT OF MALIGNANT LARYNX TUMERS PROGNOSIS

Ali Muhammad*, Mostafa Ibrahim and Ali Daoud

ABSTRACT

Background: Larynx cancer is a major challenge in ENT practice, so it requires deeper understanding, especially prognosis. Pathology in some studies on larynx cancer showed Langerhans cells infiltration in tumer stroma in some patients, which questions their role in prognosis assessment in these patients. Objective: To study the relation between langerhans cells infiltration on one side, and the malignant larynx tumers prognosis and other prognostic factors on the other side. Patients and Methods: A retrospective cohort study included patients whom biopsies from larynx tumers showed malignancy, and they had Laryngectomy in Tishreen University hospital between 2017 and 2020. Results: out of 21 cases, 16 were males (76.2%), 5 were females (23.8%), ages were between 41 and 76 years, age was converted to three groups, first from 41 to 50 years (23.8%), the second group from 51 to 60 years (28.6%), and the third group were above 60 years (47.6%), out of all cases 16 were smokers (76.2%), 4 were alcoholic (19%), Lymph node metastasis in 8 patients (38.1%), using s-100 immunostaining and morphology, minimum Langerhans infiltration was seen in 8 patients (38.1%), intermediate infiltration in 8 patients (38.1%), important infiltration in 3 patients (14.3%), and no infiltration in 2 (9.5%), and using CD1a immunostaining minimum infiltration was seen in 11 patients (52.4%), intermediate infiltration in 6 (28.6%), important infiltration in 2 (9.5%) and no infiltration in w (9.5%). the study showed statically important relation between the infiltration by Langerhans cells and the prognosis using S-100 (P-value=0.007) and using CD1a (P-value=0.003). However, no relation was shown with other prognostic factors. Conclusion: The study showed that better prognosis correlated with higher degree of Langerhans cells infiltration which indicates an important role in expecting prognosis during the treatment of larynx malignant tumers.

Keywords: Larynx cancer, Langerhans cells, S-100, CD1a.

[Full Text Article] [Download Certificate]